1-(tert-ブトキシカルボニル)-4-ピペリドン(79099-07-3)

1-(tert-ブトキシカルボニル)-4-ピペリドン 製品概要
化学名:1-(tert-ブトキシカルボニル)-4-ピペリドン
英語化学名:N-(tert-Butoxycarbonyl)-4-piperidone
别名:TIMTEC-BB SBB008535;TERT-BUTYL 4-OXOTETRAHYDRO-1(2H)-PYRIDINECARBOXYLATE;TERT-BUTYL 4-OXO-1-PIPERIDINECARBOXYLATE;T-BUTYL-4-PIPERIDONE-1-CARBOXYLATE;T-BUTOXYCARBONYL-4-PIPERIDONE;N-TERT BOC-4-PIPERIDONE;N-T-BOC-4-PIPERIDONE;N-T-BUTOXYCARBONYL-4-PIPERIDONE
CAS番号:79099-07-3
分子式:C10H17NO3
分子量:199.25
EINECS:616-664-5
カテゴリ情報:Miscellaneous Biochemicals;pharmacetical;Pyrans, Piperidines &Piperazines;Piperidine;Piperidine Series;Carbonyl Compounds;Heterocycles;Amines;blocks;Amino Acids & Derivatives;Pyrans, Piperidines & Piperazines;Piperidines;pharmaceutical;Intermediate;N-tert-Butoxyca;11;79099-07-3
Mol File:79099-07-3.mol
1-(tert-ブトキシカルボニル)-4-ピペリドン
1-(tert-ブトキシカルボニル)-4-ピペリドン 物理性質
融点 73-77 °C (lit.)
沸点 336.77°C (rough estimate)
比重(密度) 1.1249 (rough estimate)
屈折率 1.4610 (estimate)
貯蔵温度 Keep in dark place,Sealed in dry,Room Temperature
溶解性Methanol
酸解離定数(Pka)-1.58±0.20(Predicted)
外見 Crystalline Powder
White to slightly yellow
水溶解度 slightly soluble
BRN 3650236
InChIInChI=1S/C10H17NO3/c1-10(2,3)14-9(13)11-6-4-8(12)5-7-11/h4-7H2,1-3H3
InChIKeyROUYFJUVMYHXFJ-UHFFFAOYSA-N
SMILESN1(C(OC(C)(C)C)=O)CCC(=O)CC1
CAS データベース79099-07-3(CAS DataBase Reference)
安全性情報
主な危険性 Xn,Xi
Rフレーズ 36/38-22-36/37/38-20/21/22
Sフレーズ 37/39-26-36-24/25
WGK Germany 3
国連危険物分類 IRRITANT
HSコード 29333990
MSDS Information
ProviderLanguage
ACROS English
SigmaAldrich English
ALFA English
1-(tert-ブトキシカルボニル)-4-ピペリドン Usage And Synthesis
外観白色~淡黄色、結晶~結晶性粉末
用途一般工業用
用途有機合成原料。
化学的特性Light Yellow Powder
使用1-t-Boc-4-piperidone is a compound useful in organic synthesis used in the preparation of (aminoaryl)(benzyloxy)pyridines as potential antitumor agents.
使用1-Boc-4-piperidone is used as a pharmaceutical intermediate. It is involved in the preparation of 1-piperidin-4-yl-substituted butyro- and valerolactams.
主な応用N-(tert-Butoxycarbonyl)-4-piperidone is a chemical intermediate that belongs to the group of p2. It is an ancillary used in the synthesis of many organic compounds, including epidermal growth factor analogs. It has been shown to have pharmacokinetic properties that are similar to those of epidermal growth factor and can be used for the treatment of cancer. This drug has been shown to inhibit the growth of skin cancer cells and may also be useful in treating other types of cancer.
Tags:79099-07-3